<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04664621</url>
  </required_header>
  <id_info>
    <org_study_id>STU00210205</org_study_id>
    <nct_id>NCT04664621</nct_id>
  </id_info>
  <brief_title>HepQuant to Predict Hepatic Encephalopathy After TIPS</brief_title>
  <official_title>HepQuant to Predict Hepatic Encephalopathy in Patients Who Receive Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Refractory Ascites - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HepQuant, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot study to determine if a simple blood test can predict patients at risk for&#xD;
      significant episodes of confusion and disorientation that can occur in patients who receive&#xD;
      an artificial shunt through the liver to control complications of liver disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 25, 2020</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of Hepatic Encephalopathy</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Hepatic Encephalopathy</condition>
  <condition>Cirrhosis, Liver</condition>
  <arm_group>
    <arm_group_label>HepQuant Testing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>HepQuant</intervention_name>
    <description>Patients undergoing TIPS procedure will receive a HepQuant test prior to and then after TIPS.</description>
    <arm_group_label>HepQuant Testing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects over the age of 18 able to provide consent&#xD;
&#xD;
          -  Subjects undergoing initial TIPS procedure for the primary indication of treatment of&#xD;
             ascites&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Subjects undergoing TIPS placement as part of an investigational study outside of&#xD;
             usual clinical care&#xD;
&#xD;
          -  Subjects taking beta-blocker medications or angiotensin converting enzyme inhibitors&#xD;
&#xD;
          -  Subjects with evidence of porto-systemic shunts present on imaging (eg splenorenal&#xD;
             shunt)&#xD;
&#xD;
          -  Subjects with calculated MELD score &gt;12 based on most recent laboratory values before&#xD;
             consent&#xD;
&#xD;
          -  Subjects with prior history of overt hepatic encephalopathy (grade 3-4) that was&#xD;
             primary reason for hospitalization. Episodes of hepatic encephalopathy that were the&#xD;
             consequence of other precipitating event (such as variceal bleeding or infection) will&#xD;
             not be considered exclusionary.&#xD;
&#xD;
          -  Subjects with a known sensitivity to albumin preparations, any ingredient in the&#xD;
             formulation, or components of the container&#xD;
&#xD;
          -  Subjects unable to fast for &gt;5 hours prior to the HepQuant administration or subjects&#xD;
             who are unable to drink the oral dose of the cholate (~40mL of liquid).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 6, 2020</study_first_submitted>
  <study_first_submitted_qc>December 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Justin Boike</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatic Encephalopathy</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

